Perinatal Mental Health: Screening and Treatment Updates for 2026

The Growing Focus on Perinatal Mental Health

Perinatal mental health, encompassing the mental health of parents during pregnancy and the first year after birth, has received increasing attention in 2026 as research continues to demonstrate the profound impact of parental mental health on child development, family functioning, and long-term outcomes. Updated screening recommendations, new treatment options, and expanded recognition of paternal mental health needs are reshaping how counselors and social workers approach this population.

Universal Screening Recommendations

Updated Guidelines

Major professional organizations now recommend universal screening for perinatal mood and anxiety disorders (PMADs) at multiple time points during the perinatal period. Recommended screening points include the first prenatal visit, at least once during the second or third trimester, and at postpartum visits (typically at 1 to 2 weeks and 6 to 8 weeks after delivery). Some guidelines also recommend screening at well-child visits during the first year, as onset of PMADs can occur at any point during this period.

Screening Tools

The Edinburgh Postnatal Depression Scale (EPDS) remains the most widely used screening tool for perinatal depression and is also sensitive to anxiety symptoms. The EPDS has been validated across diverse populations and is available in multiple languages. The Patient Health Questionnaire (PHQ-9) is also commonly used, though it was not specifically developed for the perinatal population.

For perinatal anxiety, which is increasingly recognized as equally or more prevalent than perinatal depression, the Generalized Anxiety Disorder scale (GAD-7) and the Perinatal Anxiety Screening Scale (PASS) provide targeted assessment. Screening for perinatal OCD, which has a specific presentation during the postpartum period involving intrusive thoughts about infant harm, may require additional screening instruments.

Expanded Understanding of Perinatal Mood and Anxiety Disorders

Beyond Postpartum Depression

While postpartum depression receives the most public attention, the spectrum of perinatal mood and anxiety disorders is much broader. PMADs include prenatal depression and anxiety, postpartum depression, postpartum anxiety (including generalized anxiety, panic disorder, and social anxiety), postpartum OCD, postpartum PTSD (often related to traumatic birth experiences), and postpartum psychosis (a psychiatric emergency requiring immediate intervention).

Risk Factors

Key risk factors for PMADs include personal or family history of mood or anxiety disorders, history of PMADs in previous pregnancies, lack of social support, relationship difficulties, stressful life events during pregnancy, pregnancy or birth complications, preterm birth or infant health problems, and sleep deprivation.

Treatment Approaches

Psychotherapy

Psychotherapy is considered a first-line treatment for mild to moderate PMADs. Evidence-based approaches include CBT adapted for the perinatal period, interpersonal therapy (IPT), which addresses role transitions and relationship changes, and mindfulness-based cognitive therapy (MBCT) for relapse prevention. Group therapy and peer support programs also show promise for reducing isolation and normalizing the perinatal experience.

Pharmacological Treatment

Medication may be necessary for moderate to severe PMADs. The decision to use medication during pregnancy and breastfeeding involves careful risk-benefit analysis by the prescribing provider. Counselors should be aware of the general safety profiles of common psychiatric medications during the perinatal period and should coordinate closely with prescribers when their clients are considering or using medication.

A newer treatment option, brexanolone (marketed as Zulresso), is an FDA-approved IV infusion specifically for postpartum depression. An oral formulation (zuranolone, marketed as Zurzuvae) has also received approval, providing a more accessible pharmacological option specifically designed for postpartum depression.

Integrated Care

Integrating behavioral health screening and intervention into obstetric and pediatric care settings improves identification and treatment of PMADs. Counselors working in or consulting with these settings can facilitate warm handoffs, provide brief interventions, and ensure that identified parents are connected with appropriate treatment.

Paternal Mental Health

Research increasingly documents that new fathers also experience elevated rates of depression, anxiety, and adjustment difficulties during the perinatal period. Approximately 10% of new fathers experience depression, and rates are higher for fathers whose partners have PMADs. Paternal depression affects the father-infant relationship, the couple relationship, and child development outcomes.

Barriers to identification and treatment of paternal perinatal mental health include screening that focuses exclusively on mothers, masculine norms that discourage emotional vulnerability and help-seeking, and services that are designed primarily for mothers. Counselors can address these barriers by including fathers in screening efforts, creating father-friendly treatment environments, and normalizing the emotional challenges of the transition to parenthood for all parents.

Cultural Considerations

Perinatal mental health experiences and help-seeking behaviors are influenced by cultural beliefs about parenthood, mental illness, and appropriate roles for mothers and fathers. Some cultures have specific postpartum practices that may be protective against PMADs, while others may stigmatize perinatal mental health struggles. Culturally responsive assessment and treatment account for these variations and respect the family's cultural context while ensuring access to evidence-based care.

Implications for Practice

Stay informed about perinatal mental health screening guidelines and treatment developments. Develop competence in working with perinatal populations through continuing education and supervision. Advocate for universal screening in settings serving pregnant and postpartum families. Include fathers in your conceptualization and treatment planning. Understand the unique ethical considerations of treating clients during the perinatal period, including the intersection of parental mental health with child safety concerns.